Behroozi-Lak Tahereh, Zarei Leila, Moloody-Tapeh Mones, Farhad Negin, Mohammadi Rahim
Reproductive Health Research Center, Department of Infertility, Urmia University of Medical Sciences, Urmia, Iran.
Solid Tumor Research Center, Urmia University of Medical Sciences, Urmia, Iran.
J Pediatr Surg. 2017 Apr;52(4):602-608. doi: 10.1016/j.jpedsurg.2016.09.067. Epub 2016 Oct 14.
Ovarian torsion must be diagnosed and treated as much early as possible. The aim of the present study was to investigate effects of intraperitoneal administration of nimodipine on ischemia-reperfusion injury in ovaries.
Thirty healthy male Wistar rats weighing approximately 250g were randomized into six experimental groups (n=5): Group Sham: The rats underwent only laparotomy. Group I: A 3-h ischemia only. Group I/R: A 3-h ischemia and a 3-h reperfusion. Group I/Nimodipine: A 3-h ischemia only and 1mg/kg intraperitoneal administration of nimodipine 2.5h after induction of ischemia. Group I/R/Nimodipine: A 3-h ischemia, a 3-h reperfusion and 1mg/kg intraperitoneal administration of nimodipine 2.5h after induction of ischemia.
Nimodipine treated animals showed significantly ameliorated development of ischemia and reperfusion tissue injury compared to those of other groups (P<0.05). The significant higher values of SOD, tGSH, GPO, GSHRd and GST were observed in I/R/Nimodipine animals compared to those of other groups (P<0.05). The damage indicators (NOS, MDA, MPO and DNA damage level) were significantly lower in I/R/Nimodipine animal compared to those of other groups (P<0.05).
Intraperitoneal administration of nimodipine could be helpful in minimizing ischemia-reperfusion injury in ovarian tissue exposed to ischemia.
卵巢扭转必须尽早诊断和治疗。本研究的目的是探讨腹腔注射尼莫地平对卵巢缺血再灌注损伤的影响。
将30只体重约250g的健康雄性Wistar大鼠随机分为6个实验组(n = 5):假手术组:大鼠仅接受剖腹手术。I组:仅3小时缺血。I/R组:3小时缺血和3小时再灌注。I/尼莫地平组:仅3小时缺血且在缺血诱导后2.5小时腹腔注射1mg/kg尼莫地平。I/R/尼莫地平组:3小时缺血、3小时再灌注且在缺血诱导后2.5小时腹腔注射1mg/kg尼莫地平。
与其他组相比,尼莫地平治疗的动物缺血和再灌注组织损伤的发展明显改善(P<0.05)。与其他组相比,I/R/尼莫地平组动物的SOD、tGSH、GPO、GSHRd和GST值显著更高(P<0.05)。与其他组相比,I/R/尼莫地平组动物的损伤指标(NOS、MDA、MPO和DNA损伤水平)显著更低(P<0.05)。
腹腔注射尼莫地平有助于将暴露于缺血的卵巢组织中的缺血再灌注损伤降至最低。